Nautilus Biotechnolgy
NAUT
75 hedge funds and large institutions have $142M invested in Nautilus Biotechnolgy in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 5 closing their positions.
108% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 12
0.2% more ownership
Funds ownership: 35.89% → 36.09% (+0.2%)
0% more funds holding
Funds holding: 75 → 75 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
18% less capital invested
Capital invested by funds: $173M → $142M (-$31M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$531K |
| 2 |
BlackRock
New York
|
+$438K |
| 3 |
Corient Private Wealth
Miami,
Florida
|
+$148K |
| 4 |
SG Americas Securities
New York
|
+$72.8K |
| 5 |
ST
Sentinel Trust
Houston,
Texas
|
+$65.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$138K |
| 2 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$96.8K |
| 3 |
Mariner
Overland Park,
Kansas
|
-$73K |
| 4 |
Morgan Stanley
New York
|
-$62.7K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$50.6K |
NAUT Hedge Fund Activity: Q3 2023 in Review
75 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q3 2023, worth a combined $142M — down 18% from $173M a quarter earlier.
Fund positioning in NAUT was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 25 added to existing stakes and 12 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $531K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $138K sold.
- 75 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $142M of Nautilus Biotechnolgy stock for Q3 2023, down 18% quarter-over-quarter.
- 5 funds opened new Nautilus Biotechnolgy positions in Q3 2023 and 5 closed out, a net change of 0 holders.
- The largest Nautilus Biotechnolgy buyer in Q3 2023 was Dimensional Fund Advisors, an estimated $531K added.
- The largest Nautilus Biotechnolgy seller in Q3 2023 was Susquehanna International Group, an estimated $138K sold.
Based on aggregated 13F filings for Q3 2023.